February 26, 2026, 11:00 AM – 12:00 PM EST
In cell and gene therapy, many critical determinants of success are most effectively addressed early, before launch, while others will continue to evolve as the launch unfolds. Anticipating these challenges from the outset is essential for achieving and successful launch with sustained impact. Teams must be ready to navigate high manufacturing and logistical complexity, intense payer and HTA scrutiny, evolving system adoption barriers, and the need to demonstrate lasting value for small and often rare patient populations.
In this webinar, Michael Parisi will moderate a dynamic conversation with Ted Slocomb and Joe DePinto, two leaders whose experience spans global commercialization, operational execution, and market access for some of the most advanced therapies brought to market. Together, they will explore how to apply Lumanity’s Value Inflection Point framework to anticipate challenges, align stakeholder needs, and build the foundations for both launch and long-term success.
Attendees will gain a 360‑degree perspective that blends strategic foresight with practical, real‑world lessons, helping teams navigate the high stakes, rapid evolution, and unique demands of the CGT marketplace.